Glenmark Pharma Q2 Results : Co posts Rs 355 crore net profit on robust sales (...)
Glenmark Pharma reported Rs 340 crore net profit in Q2FY25 led by robust sales growth in India and Europe. The drugmaker reported a net loss of Rs 180 crore in the corresponding quarter of the previous year.
Site référencé: The Economic Times
The Economic Times
From global agreements to local action : India’s opportunity to lead the way in VDA governance
3/08/2025
Why Indian investors should look at Silver in 2025 : The metal poised for growth
3/08/2025
I am fully desi now, says Motilal Oswal after buying new Mahindra car
3/08/2025
Wild history of jailed Kazakh ex-Premier’s $3 mn mansion makes it a tough sell in a soft market
3/08/2025
